Assignee
APHIOS CORP
US·18 granted patents·19 pending applications·650 citations·filing 1992–2024
Top patents by PatentIndex Score
37 records- 0193US5750709AMethod and apparatus for isolating therapeutic compositions from source materialsAPHIOS CORP·Filed 1995·Granted May 12, 1998·62 cites·21 claims
- 0292US5554382AMethods and apparatus for making liposomesAPHIOS CORP·Filed 1993·Granted Sep 10, 1996·133 cites·31 claims
- 0389US5776486AMethods and apparatus for making liposomes containing hydrophobic drugsAPHIOS CORP·Filed 1996·Granted Jul 7, 1998·123 cites·31 claims
- 0489US5440055AMethod and apparatus for extracting taxol from source materialsAPHIOS CORP·Filed 1993·Granted Aug 8, 1995·35 cites·21 claims
- 0586US10954248B2Bryoid compositions, methods of making and use thereofAPHIOS CORP·Filed 2018·Granted Mar 23, 2021·1 cites·3 claims
- 0686US10493030B2Combination HIV therapeuticAPHIOS CORP·Filed 2016·Granted Dec 3, 2019·2 cites·24 claims
- 0786US7147806B2Polymer microspheres/nanospheres and encapsulating therapeutic proteins thereinAPHIOS CORP·Filed 2004·Granted Dec 12, 2006·17 cites·17 claims
- 0884US9034347B2Drug delivery system and method for the treatment of neuro-degenerative diseaseAPHIOS CORP·Filed 2012·Granted May 19, 2015·6 cites·5 claims
- 0982US5877005AViral inactivation method using near critical, supercritical or critical fluidsAPHIOS CORP·Filed 1995·Granted Mar 2, 1999·140 cites·12 claims
- 1082US5380826ASupercritical fluid disruption of and extraction from microbial cellsAPHIOS CORP·Filed 1992·Granted Jan 10, 1995·74 cites·10 claims
- 1181US9994585B2Transplantation therapiesAPHIOS CORP·Filed 2014·Granted Jun 12, 2018·2 cites·16 claims
- 1277US2024252437A1Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity EnvironmentAPHIOS CORP·Filed 2024·Application pending·0 cites
- 1372US6569640B1Method of fractionation of biologically-derived materials using critical fluidsAPHIOS CORP·Filed 1998·Granted May 27, 2003·29 cites·8 claims
- 1468US10723744B2Transplantation therapiesAPHIOS CORP·Filed 2018·Granted Jul 28, 2020·0 cites·17 claims
- 1565US7037534B2Inactivation of viral infections agents by chemiluminescence activated light-sensitive compoundsAPHIOS CORP·Filed 2002·Granted May 2, 2006·3 cites·14 claims
- 1664US2020199146A1Transplantation TherapiesAPHIOS CORP·Filed 2020·Application pending·0 cites
- 1764US2016008377A1Formulations and compositions of vitamin d analogs for treating and preventing cancer and other diseasesAPHIOS CORP·Filed 2014·Application pending·0 cites
- 1864US2022313610A1Methods for and products from encapsulation of drugs in nanoparticles in a microgravity environmentAPHIOS CORP·Filed 2021·Application pending·0 cites
- 1963US2010166806A1Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latencyAPHIOS CORP·Filed 2008·Application pending·0 cites
- 2062US2020199145A1Transplantation TherapiesAPHIOS CORP·Filed 2020·Application pending·0 cites
- 2161US10258635B2Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseasesAPHIOS CORP·Filed 2016·Granted Apr 16, 2019·0 cites·4 claims
- 2261US2015291616A1Bryoid compositions, methods of making and use thereofAPHIOS CORP·Filed 2013·Application pending·0 cites
- 2361US2005059641A1Compositions and methods for treating and preventing cancer using analogs of vitamin DAPHIOS CORP·Filed 2004·Application pending·0 cites
- 2460US2018272307A1Apparatus and methods for making nanosomes loaded with nucleic acidAPHIOS CORP·Filed 2018·Application pending·0 cites
- 2556US10828276B2Combination therapeutics and methods for the treatment of neurodegenerative and other diseasesAPHIOS CORP·Filed 2013·Granted Nov 10, 2020·0 cites·18 claims
- 2655US2005106111A1Compositions and methods for reducing dental plaqueAPHIOS CORP·Filed 2004·Application pending·0 cites
- 2755US2020397701A1Drug delivery system and method for the treatment of neuro-degenerative diseaseAPHIOS CORP·Filed 2019·Application pending·0 cites
- 2853US5854064AMethods for fractionation of biologically-derived materialsAPHIOS CORP·Filed 1996·Granted Dec 29, 1998·23 cites·8 claims
- 2953US2005118282A1Compositions and methods for inhibiting 5-alpha reductaseAPHIOS CORP·Filed 2004·Application pending·0 cites
- 3052US2009288788A1Pretreating cellulosic biomassAPHIOS CORP·Filed 2008·Application pending·0 cites
- 3151US10485766B2Drug delivery system and method for the treatment of neuro-degenerative diseaseAPHIOS CORP·Filed 2015·Granted Nov 26, 2019·0 cites·5 claims
- 3251US2006240098A1Formulations for hyperforin-enriched hypericum fractionsAPHIOS CORP·Filed 2005·Application pending·0 cites
- 3351US2005095283A1Compositions and methods for topically treating diseasesAPHIOS CORP·Filed 2004·Application pending·0 cites
- 3450US2013122106A1Dosage form, and methods of making and using the same, to produce immunization in animals and humansAPHIOS CORP·Filed 2012·Application pending·0 cites
- 3548US2006269928A1Compositions, methods and apparatus for supercritical fluid virus inactivationAPHIOS CORP·Filed 2005·Application pending·0 cites
- 3648US2014080114A1Methods, kits and compositions for inactivation of viral agents in whole blood and red blood cell concentratesAPHIOS CORP·Filed 2013·Application pending·0 cites
- 3747US2022016120A1Methods and products for treating folic acid deficiency and morning sicknessAPHIOS CORP·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →